01 · The Goal

Catch loss early and protect joints before it fades

The goal is to catch loss at its very start and preserve joints — catching joint damage early and protecting cartilage before it wears down. This matters because of who is on the other side of it: people who would get their health, and their independence, back.

02 · Why It Matters

Cartilage cushions every joint and barely heals on its own — once it wears away, the result is osteoarthritis, pain, and lost mobility for hundreds of millions. Repairing cartilage early, restoring joint movement, and keeping joints resilient for life would spare a vast share of the world’s disability and joint-replacement surgery. For the hundreds of millions with worn joints, this is the difference between a life narrowed by pain and one lived in full motion.

03 · What We’re Trying to Achieve

We are building the capability to detect decline years before symptoms and act early to preserve joints. The work runs from proven clinical care now to the frontier science still maturing — and this page marks exactly where each piece stands.

04 · How It Works

How it works

Early detection Demonstrated in research

Sensitive tests reveal early decline before it becomes irreversible.

Acting in the silent stage Clinical

Treating risk and early disease preserves function longer — established.

Continuous monitoring Frontier

AI-supported tracking that flags subtle loss early, always with a clinician, is emerging.

Personalized early action Advancing — some clinical

Tailoring early intervention to each person’s biology, guided by sensitive tests and clinician oversight, preserves function for longer.

05 · Who’s Building It

Cited as evidence the capability is real — not as partners or endorsers.

Government & programs

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS, NIH) · NIH regenerative-medicine programs. These public programs fund the foundational research that shows the capability is real.

Universities & institutes

Academic orthopaedics, cartilage-regeneration, and joint-biology research centers. Academic laboratories carry that science from discovery toward the clinic.

Enabling science base

chondrocyte & cartilage-matrix biology · joint stem cells · cartilage tissue engineering · biomechanics. — the established disciplines this capability is built upon.

06 · Technologies

The technologies: cartilage cell and matrix therapies, tissue-engineered cartilage, joint-preserving early interventions, and the biomechanics and rehabilitation that keep joints moving.

07 · Breakthroughs

Pre-symptom detection Demonstrated

Decline is found before symptoms.

Early intervention Clinical

Acting early preserves function.

Monitoring Frontier

Continuous early warning is emerging.

Earlier detection windows Demonstrated in research

Each advance in biomarkers and imaging pushes detection earlier, widening the window in which loss can still be prevented.

08 · Remaining Challenges

The honest challenges: we can detect loss earlier than we can fully stop it. Preservation depends on detection (demonstrated) maturing alongside protection (clinical/frontier). We can see decline earlier than we can fully stop it, and disease-modifying treatment is still emerging — so preservation depends on detection and protection maturing together. Each piece is tagged for exactly where it stands today.

09 · Mature Capability

The future, fully built

Joints is watched over and preserved — loss caught at the first sign and halted before it fades — so decline is prevented rather than diagnosed too late. — and the honest staging on this page shows just how much of that future is already real, and how much is still being built.

Honest boundary: each item is tagged for where it stands — demonstrated, clinical, or frontier. The science is real, funded, and accelerating. AI supports human clinicians; it never replaces them.
10 · Evidence Vault

The proof, for this capability

Cited as evidence the capability is real, not as partners or endorsers.

Early detection

Sensitive tests find early decline. Stage: Demonstrated.

Silent-stage care

Acting early preserves function. Stage: Clinical.

Monitoring

Continuous early warning is emerging. Stage: Frontier.

Honest framing

Real organizations are cited as evidence the capability is real — not as partners or endorsers. Detection is demonstrated; fully halting loss is emerging and not claimed as routine.

Where it stands

Each line above is tagged for its stage — demonstrated, clinical, or frontier — so the page shows exactly how far the real science has come, and how far is left.

Help build this future

Every signature grows the movement to make joint preservation real — and free at the point of need.

Paid for by Michael Floyd for President.

Scroll to Top